We observed higher mRNA expression levels, especially for the mitotic factors identified at stressed replication forks in breast and prostate cancer patients with BRCA1/2 mutations compared to the respective BRCA1/2 wild-type cancers (Figure 3C, Supplementary Figure S3d). This evidence concerns the gene BRCA1 and Familial prostate cancer.